Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.
Volume 26, Number 9—September 2020
Zika Virus Infection, Philippines, 2012
To the Editor: Alera et al. described a 2012 case of Zika virus infection in the Philippines (1). In 2007, a Zika virus outbreak occurred in Yap, Micronesia, possibly caused by travelers from the Philippines (2). Zika virus infections were reported in the Philippines in 1953, 2012, and 2016 (3). Although frequent travel exchange between Yap and the Philippines could be a possible transmission route, no data on Zika virus infection were recorded in the Philippines between 1953 and 2012.
We detected Zika virus infection in 1 (0.75%) of 134 febrile, non–dengue infected patients at St. Luke’s Medical Center (Quezon City, the Philippines) during 2010–2015 by subjecting patient serum samples to serological and molecular tests. Ethics clearance (reference no. 19042) for this study was given by St. Luke’s Medical Center Institutional Ethics Review Committee. The only patient who tested positive for Zika virus was a 31-year-old woman diagnosed with an upper respiratory tract infection in 2010. Because of her work, she might not have traveled internationally. We obtained her serum sample on day 3 of fever. She did not have a rash or arthralgia. Although we did not isolate Zika virus according to guidelines (4), we confirmed infection using other techniques. The patient’s serum sample tested positive for Zika virus RNA, IgM against Zika virus, and neutralizing antibodies against Zika virus by using a plaque reduction neutralization test to neutralize 50% of plaques (PRNT50) (PRNT50 Zika virus = 1:80, PRNT50 dengue virus serotypes 1–4 <1:10). The sample tested negative for IgM against dengue and Japanese encephalitis viruses but positive for IgG against Zika virus nonstructural protein 1. These results suggest local Zika virus infection in the Philippines since at least 2010, 2 years earlier than the previously reported infection (1).
This work was supported by the Agency for Research and Development (AMED) under grant no. AMED JP20wm0125006, AMED Research on Emerging and Re-emerging Infectious Diseases (grant nos. 19fk0108109h0001, 20fk0108109h0001, 20fk0108123h1101) and the Joint Usage/Research Center on Tropical Disease, Institute of Tropical Medicine, Nagasaki University (grant no. 2020-Ippan-21). Partial support came from the Research and Biotechnology Group, St. Luke’s Medical Center, Quezon City, Philippines (project no. 07-024).
- Alera MT, Hermann L, Tac-An IA, Klungthong C, Rutvisuttinunt W, Manasatienkij W, et al. Zika virus infection, Philippines, 2012. Emerg Infect Dis. 2015;21:722–4.
- Musso D, Gubler DJ. Zika Virus. Clin Microbiol Rev. 2016;29:487–524.
- Duong V, Dussart P, Buchy P. Zika virus in Asia. Int J Infect Dis. 2017;54:121–8.
- Centers for Disease Control and Prevention. Testing for Zika virus infection. 2019 Jun 13 [cited 2020 Jun 11]. https://www.cdc.gov/zika/laboratories/types-of-tests.html
Suggested citation for this article: Buerano CC, Pangilinan L-AS, Dimamay MTA, Mapua CA, Dimamay MPS, Matias RR, et al. Zika virus infection, Philippines, 2012. Emerg Infect Dis. 2020 Sep [date cited]. https://doi.org/10.3201/eid2609.190896
Original Publication Date: July 27, 2020